Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02235792 · ClinicalTrials.gov registry record · Phase 1
High Frequency Oscillations in Neurologic Disease
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT02235792: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT02235792 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02235792, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study is designed to evaluate the high-frequency range deep brain oscillations (HFO) as pathologic markers in patients undergoing deep brain stimulation for epilepsy or Parkinson disease. Newly developed technology allows for the chronic recording of these brain signals at the same time as clinical stimulation is occuring. We will learn both whether these HFO correlate with disease activity and whether the HFO change in response to ongoing stimulation (potentially giving insight into the underlying mechanism of action of DBS).
Interventions
- DEVICE Activa PC+S
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-07 |
| Est. Completion | 2020-11-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02235792
The ClinicalTrials.gov registry entry for NCT02235792 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Activa PC+S is the first listed.
NCT02235792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02235792 about?
NCT02235792 is a clinical study titled "High Frequency Oscillations in Neurologic Disease". This study is designed to evaluate the high-frequency range deep brain oscillations (HFO) as pathologic markers in patients undergoing deep brain stimulation for epilepsy or Parkinson disease. Newly developed technology allows for the chronic recording of these brain signals at the same time as clin...
What is the current status of trial NCT02235792?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2014-07. Estimated completion is 2020-11-20.
What interventions are being tested in trial NCT02235792?
The interventions under investigation include: Activa PC+S (DEVICE).
Who is sponsoring clinical trial NCT02235792?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.